Tải bản đầy đủ (.pdf) (3 trang)

Andersons pediatric cardiology 1674

Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.6 KB, 3 trang )

cardiomyopathyduetoFabry'sdisease.NEnglJ
Med.1982;307(15):926–928.
174.NakaoS,TakenakaT,MaedaM,etal.An
atypicalvariantofFabry'sdiseaseinmenwith
leftventricularhypertrophy.NEnglJMed.
1995;333(5):288–293.
175.vonScheidtW,EngCM,FitzmauriceTF,etal.
AnatypicalvariantofFabry'sdiseasewith
manifestationsconfinedtothemyocardium.N
EnglJMed.1991;324(6):395–399.
176.WilsonHC,HopkinRJ,MaduemePC,etal.
Arrhythmiaandclinicalcardiacfindingsin
childrenwithAnderson-fabrydisease.AmJ
Cardiol.2017.
177.ShahJS,HughesDA,SachdevB,etal.
Prevalenceandclinicalsignificanceofcardiac
arrhythmiainAnderson-fabrydisease.AmJ
Cardiol.2005;96(6):842–846.
178.PatelV,O'MahonyC,HughesD,etal.Clinical
andgeneticpredictorsofmajorcardiaceventsin
patientswithAnderson-fabrydisease.Heart.
2015;101(12):961–966.
179.HopkinRJ,BisslerJ,BanikazemiM,etal.
Characterizationoffabrydiseasein352
pediatricpatientsinthefabryregistry.Pediatr
Res.2008;64(5):550–555.
180.MehtaA,ClarkeJT,GiuglianiR,etal.Natural


courseoffabrydisease:changingpatternof
causesofdeathinFOS-fabryoutcomesurvey.J


MedGenet.2009;46(8):548–552.
181.FrustaciA,ChimentiC,RicciR,etal.
Improvementincardiacfunctioninthecardiac
variantofFabry'sdiseasewithgalactoseinfusiontherapy.NEnglJMed.
2001;345(1):25–32.
182.TondelC,BostadL,LarsenKK,etal.
Agalsidasebenefitsrenalhistologyinyoung
patientswithfabrydisease.JAmSocNephrol.
2013;24(1):137–148.
183.ChimentiC,PieroniM,MorganteE,etal.
Prevalenceoffabrydiseaseinfemalepatients
withlate-onsethypertrophiccardiomyopathy.
Circulation.2004;110(9):1047–1053.
184.SachdevB,TakenakaT,TeraguchiH,etal.
PrevalenceofAnderson-fabrydiseaseinmale
patientswithlateonsethypertrophic
cardiomyopathy.Circulation.
2002;105(12):1407–1411.
185.EngelAG,GomezMR,SeyboldME,Lambert
EH.Thespectrumanddiagnosisofacidmaltase
deficiency.Neurology.1973;23(1):95–106.
186.vandenHoutHM,HopW,vanDiggelenOP,et
al.ThenaturalcourseofinfantilePompe's
disease:20originalcasescomparedwith133


casesfromtheliterature.Pediatrics.
2003;112(2):332–340.
187.KishnaniPS,HwuWL,MandelH,etal.A
retrospective,multinational,multicenterstudy

onthenaturalhistoryofinfantile-onsetpompe
disease.JPediatr.2006;148(5):671–676.
188.LaforetP,NicolinoM,EymardPB,etal.
Juvenileandadult-onsetacidmaltasedeficiency
inFrance:genotype-phenotypecorrelation.
Neurology.2000;55(8):1122–1128.
189.WinkelLP,HagemansML,vanDoornPA,etal.
Thenaturalcourseofnon-classicPompe's
disease;areviewof225publishedcases.J
Neurol.2005;252(8):875–884.
190.WokkeJH,AusemsMG,vandenBoogaardMJ,
etal.Genotype-phenotypecorrelationinadultonsetacidmaltasedeficiency.AnnNeurol.
1995;38(3):450–454.
191.KishnaniPS,CorzoD,NicolinoM,etal.
Recombinanthumanacid[alpha]-glucosidase:
majorclinicalbenefitsininfantile-onsetpompe
disease.Neurology.2007;68(2):99–109.
192.LevineJC,KishnaniPS,ChenYT,HerlongJR,
LiJS.Cardiacremodelingafterenzyme
replacementtherapywithacidalpha-glucosidase
forinfantswithpompedisease.PediatrCardiol.
2008;29(6):1033–1042.



×